Forepont Capital Partners invests in biotech, medtech, and e-health startups in the United States and Europe, providing scientific, technological, financial, and operational support. The firm operates a unique philanthropy-investment hybrid model, funding basic research while investing in resulting startups, with a focus on advancing medical research and innovation, particularly in neurology.
About Forepont Capital Partners
Forepont Capital Partners is a healthcare-focused investment firm with a thesis spanning healthcare services, medical technology, and healthcare-adjacent businesses, operating in private equity and growth equity rather than early-stage venture. The forepont.com website and LinkedIn presence indicate an established healthcare specialist with a focus on revenue-stage and profitable businesses. For healthcare AI founders, Forepont is the right type of investor only if you are running a revenue-stage healthcare business with proven economics; this is not a seed or Series A shop. Plausible check sizes run 5M to 30M for control or significant minority positions in healthcare services and technology businesses with multi-million-dollar revenue. Founders running profitable healthcare AI services companies, healthcare technology companies with demonstrated payer or provider contracts, or rollup-amenable healthcare businesses augmented with AI tooling are the target profile. Founders at seed, Series A, or pre-revenue stages should not approach. Founders building pure-play AI infrastructure or research-stage technology should also pass; Forepont underwrites operating businesses with cash flow, not platform technology bets. Entry path is warm introduction through healthcare investment bankers, healthcare services operators, or portfolio CEOs. The firm does not advertise an open submission process, and at this stage and check size, formal banker-led processes are the norm. Diligence will focus on unit economics, regulatory exposure, reimbursement durability, and operator quality. Expect a thorough, slow process oriented around growth equity discipline rather than venture pace. The healthcare specialization is real, which means the questions will be sharp and the value-add credible if you fit the profile.
Founder reviews
Other portfolio companies
Companies in Forepont Capital Partners's portfolio not currently in our directory.
- AlterDiag
- Predict4Health
- Precision Neuroscience
- Synchron
- BeCareLink
- Blackrock Neurotech
- Invicta Medical (Restera)
- GPN Vaccines
- BCV
- Ansella Therapeutics
- BioSpeedia
- Exeliom Biosciences
Team
Pitch / review this investor
Have you raised from Forepont Capital Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).